Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 157 results
Author Title [ Year(Asc)]
Filters: Author is Aplenc, Richard  [Clear All Filters]
2021
Mangum DSpencer, Meyer JA, Mason CC, et al. "Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia." JAMA Oncol. 2021.
van Dijk AD, Hoff FW, Qiu Y, et al. "Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA." Proteomics Clin Appl. 2021:e2100072.
Elgarten CW, Li Y, Getz KD, et al. "Broad spectrum antibiotics and risk of graft-versus-host disease in pediatric patients transplanted for acute leukemia: association of carbapenem use with risk of acute GVHD." Transplant Cell Ther. 2021;27(2):177.e1-177.e8.
Huang BJ, Smith J, Wang J, et al. "CBFB-MYH11 Fusion Transcripts Distinguish Acute Myeloid Leukemias with Distinct Molecular Landscapes and Outcomes." Blood Adv. 2021.
Lamble AJ, Brodersen LEidenschin, Alonzo TA, et al. "CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group." J Clin Oncol. 2021:JCO2101595.
Leahy ABarz, Newman H, Li Y, et al. "CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials." Lancet Haematol. 2021;8(10):e711-e722.
Tarlock K, Lamble A, Wang J, et al. "CEBPA bZip Mutations are Associated with Favorable Prognosis in de novo AML: A Report from the Children's Oncology Group." Blood. 2021.
O'Connor MJ, Zhang X, Griffis H, et al. "Center Variation in Indication and Short-Term Outcomes after Pediatric Heart Transplantation: Analysis of a Merged United Network for Organ Sharing - Pediatric Health Information System Cohort." Pediatr Cardiol. 2021.
Miller TP, Marx MZ, Henchen C, et al. "Challenges and Barriers to Adverse Event Reporting in Clinical Trials: A Children's Oncology Group Report." J Patient Saf. 2021.
Lalonde E, Rentas S, Wertheim G, et al. "Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies." Cold Spring Harb Mol Case Stud. 2021;7(2).
Getz KD, Alonzo TA, Sung L, et al. "Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2021:e29313.
Leahy ABarz, Schwartz LA, Li Y, et al. "Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy." Cancer. 2021.
Miller TP, Aplenc R. "Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery." Curr Hematol Malig Rep. 2021.
Pollard JA, Guest E, Alonzo TA, et al. "Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric -Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531." J Clin Oncol. 2021:JCO2003048.
Myers RM, Li Y, Leahy ABarz, et al. "Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia." J Clin Oncol. 2021:JCO2003458.
Rosenfeld E, Getz KD, Miller TP, et al. "Incidence and risk factors for hypoglycemia during maintenance chemotherapy in pediatric acute lymphoblastic leukemia." Pediatr Blood Cancer. 2021:e29467.
Chow EJ, Aplenc R, Vrooman LM, et al. "Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group." Cancer. 2021.
Getz KD, Szymczak JE, Li Y, et al. "Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia." JAMA Netw Open. 2021;4(10):e2128385.
Getz KD, Lewey J, Tam V, et al. "Neighborhood education status drives racial disparities in clinical outcomes in PPCM." Am Heart J. 2021.
Getz KD, Lewey J, Tam V, et al. "Neighborhood education status drives racial disparities in clinical outcomes in PPCM." Am Heart J. 2021;238:27-32.
Elgarten CW, Wood AC, Li Y, et al. "Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2021:e29281.

Pages